GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » EPS Bio Technology Corp (ROCO:4183) » Definitions » Debt-to-Equity

EPS Bio Technology (ROCO:4183) Debt-to-Equity : 0.36 (As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is EPS Bio Technology Debt-to-Equity?

EPS Bio Technology's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was NT$5.7 Mil. EPS Bio Technology's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was NT$108.7 Mil. EPS Bio Technology's Total Stockholders Equity for the quarter that ended in Mar. 2024 was NT$317.8 Mil. EPS Bio Technology's debt to equity for the quarter that ended in Mar. 2024 was 0.36.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for EPS Bio Technology's Debt-to-Equity or its related term are showing as below:

ROCO:4183' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.1   Med: 0.39   Max: 0.49
Current: 0.36

During the past 13 years, the highest Debt-to-Equity Ratio of EPS Bio Technology was 0.49. The lowest was 0.10. And the median was 0.39.

ROCO:4183's Debt-to-Equity is ranked worse than
61.69% of 697 companies
in the Medical Devices & Instruments industry
Industry Median: 0.22 vs ROCO:4183: 0.36

EPS Bio Technology Debt-to-Equity Historical Data

The historical data trend for EPS Bio Technology's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EPS Bio Technology Debt-to-Equity Chart

EPS Bio Technology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.46 0.43 0.42 0.39 0.38

EPS Bio Technology Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.39 0.41 0.39 0.38 0.36

Competitive Comparison of EPS Bio Technology's Debt-to-Equity

For the Medical Devices subindustry, EPS Bio Technology's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EPS Bio Technology's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, EPS Bio Technology's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where EPS Bio Technology's Debt-to-Equity falls into.



EPS Bio Technology Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

EPS Bio Technology's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

EPS Bio Technology's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


EPS Bio Technology  (ROCO:4183) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


EPS Bio Technology Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of EPS Bio Technology's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


EPS Bio Technology (ROCO:4183) Business Description

Traded in Other Exchanges
N/A
Address
No.8, R&D RD III, Hsinchu Science Park, Hsinchu, TWN, 30077
EPS Bio Technology Corp operates in the medical industry. The company is a manufacturer of glucose meter and strips to develop diabetic self-monitoring blood glucose system. Its product includes MDT2, EME and EMMU.

EPS Bio Technology (ROCO:4183) Headlines

No Headlines